Patents by Inventor Vincenza Corsa

Vincenza Corsa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation and purification of the sodium salt of hyaluronic acid
    Patent number: 11395833
    Abstract: The present invention concerns a process for the preparation and purification of the sodium salt of HA from the fermentation broth of Streptococcus or Bacillus or from rooster combs, the sodium salt of HA obtained and purified with said process and pharmaceutical, cosmetic and nutritional compositions comprising said sodium salt of HA.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: July 26, 2022
    Assignee: FIDIA FARMACEUTICI S.p.A.
    Inventors: Mara Pittarello, Francesco Borile, Vincenza Corsa
  • Process for the purification of hyaluronic acid
    Patent number: 11198742
    Abstract: A process is described for the purification of HA, and pharmaceutical, cosmetic and nutritional compositions containing HA thus purified.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: December 14, 2021
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza Corsa, Giancarlo Carpanese
  • PROCESS FOR THE PREPARATION AND PURIFICATION OF THE SODIUM SALT OF HYALURONIC ACID
    Publication number: 20210046103
    Abstract: The present invention concerns a process for the preparation and purification of the sodium salt of HA from the fermentation broth of Streptococcus or Bacillus or from rooster combs, the sodium salt of HA obtained and purified with said process and pharmaceutical, cosmetic and nutritional compositions comprising said sodium salt of HA.
    Type: Application
    Filed: October 30, 2020
    Publication date: February 18, 2021
    Applicant: FIDIA FARMACEUTICI S.p.A.
    Inventors: Mara PITTARELLO, Francesco BORILE, Vincenza CORSA
  • Process for the preparation and purification of the sodium salt of hyaluronic acid
    Patent number: 10849925
    Abstract: The present invention concerns a process for the preparation and purification of the sodium salt of HA from the fermentation broth of Streptococcus or Bacillus or from rooster combs, the sodium salt of HA obtained and purified with said process and pharmaceutical, cosmetic and nutritional compositions comprising said sodium salt of HA.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: December 1, 2020
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Mara Pittarello, Francesco Borile, Vincenza Corsa
  • Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives
    Patent number: 10821131
    Abstract: The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: November 3, 2020
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Anna Maria Zanellato, Vincenza Corsa, Giancarlo Carpanese, Monica Campisi
  • PROCESS FOR THE PREPARATION AND PURIFICATION OF THE SODIUM SALT OF HYALURONIC ACID
    Publication number: 20190224232
    Abstract: The present invention concerns a process for the preparation and purification of the sodium salt of HA from the fermentation broth of Streptococcus or Bacillus or from rooster combs, the sodium salt of HA obtained and purified with said process and pharmaceutical, cosmetic and nutritional compositions comprising said sodium salt of HA.
    Type: Application
    Filed: July 27, 2017
    Publication date: July 25, 2019
    Applicant: FIDIA FARMACEUTICI S.p.A.
    Inventors: Mara PITTARELLO, Francesco BORILE, Vincenza CORSA
  • PROCESS FOR THE PURIFICATION OF HYALURONIC ACID
    Publication number: 20190023813
    Abstract: A process is described for the purification of HA, and pharmaceutical, cosmetic and nutritional compositions containing HA thus purified.
    Type: Application
    Filed: July 17, 2018
    Publication date: January 24, 2019
    Applicant: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza CORSA, Giancarlo CARPANESE
  • Process for the production of hyaluronic acid in or
    Patent number: 10017802
    Abstract: The present invention relates to a method for the production of hyaluronic acid (HA) in Bacillus subtilis and Escherichia coli through plasmid vectors wherein the gene is under the control of strong promoter Pgrac, and a system for the selection of stable bacterial strains for the production of high levels of hyaluronic acid.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: July 10, 2018
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza Corsa, Alessandro Negro, Susanna Vaccaro, Luciano Messina
  • PHARMACEUTICAL FORMULATIONS COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID DERIVATIVES
    Publication number: 20170216344
    Abstract: The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.
    Type: Application
    Filed: April 17, 2017
    Publication date: August 3, 2017
    Applicant: FIDIA FARMACEUTICI S.p.A.
    Inventors: Anna Maria ZANELLATO, Vincenza CORSA, Giancarlo CARPANESE, Monica CAMPISI
  • Process for the production of hyaluronic acid in or bacillus megaterium
    Patent number: 9695453
    Abstract: A method of producing hyaluronic acid (HA) in Escherichia coli and Bacillus megaterium through episomal plasmid vectors wherein the gene is under the control of strong promoter T7, preferably under the control of strong promoter T7 of bacteriophage T7, and a system for the selection of stable bacterial strains producing high levels of hyaluronic acid, are provided.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: July 4, 2017
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza Corsa, Alessandro Negro, Sonia Bisicchia
  • Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives
    Patent number: 9655918
    Abstract: The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: May 23, 2017
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Anna Maria Zanellato, Vincenza Corsa, Giancarlo Carpanese, Monica Campisi
  • PROCESS FOR THE PRODUCTION OF HYALURONIC ACID IN ESCHERICHIA COLI OR BACILLUS SUBTILIS
    Publication number: 20160237465
    Abstract: The present invention relates to a method for the production of hyaluronic acid (HA) in Bacillus subtilis and Escherichia coli through plasmid vectors wherein the gene is under the control of strong promoter Pgrac, and a system for the selection of stable bacterial strains for the production of high levels of hyaluronic acid.
    Type: Application
    Filed: February 17, 2016
    Publication date: August 18, 2016
    Applicant: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza CORSA, Alessandro NEGRO, Susanna VACCARO, Luciano MESSINA
  • Method for obtaining recombinant host bacterial cells that produce hyaluronic acid
    Patent number: 9290785
    Abstract: The present invention relates to a method for the production of hyaluronic acid (HA) in Bacillus subtilis and Escherichia coli through plasmid vectors wherein the gene is under the control of strong promoter Pgrac, and a system for the selection of stable bacterial strains for the production of high levels of hyaluronic acid.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: March 22, 2016
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza Corsa, Alessandro Negro, Susanna Vaccaro, Luciano Messina
  • PROCESS FOR THE PRODUCTION OF HYALURONIC ACID IN ESCHERICHIA COLI OR BACILLUS MEGATERIUM
    Publication number: 20160032337
    Abstract: A method of producing hyaluronic acid (HA) in Escherichia coli and Bacillus megaterium through episomal plasmid vectors wherein the gene is under the control of strong promoter T7, preferably under the control of strong promoter T7 of bacteriophage T7, and a system for the selection of stable bacterial strains producing high levels of hyaluronic acid, are provided.
    Type: Application
    Filed: October 15, 2015
    Publication date: February 4, 2016
    Applicant: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza CORSA, Alessandro NEGRO, Sonia BISICCHIA
  • Process for the production of hyaluronic acid in or
    Patent number: 9163270
    Abstract: A method of producing hyaluronic acid (HA) in Escherichia coli and Bacillus megaterium through episomal plasmid vectors wherein the gene is under the control of strong promoter T7, preferably under the control of strong promoter T7 of bacteriophage T7, and a system for the selection of stable bacterial strains producing high levels of hyaluronic acid, are provided.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: October 20, 2015
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza Corsa, Alessandro Negro, Sonia Bisicchia
  • PHARMACEUTICAL FORMULATIONS COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID DERIVATIVES
    Publication number: 20150072954
    Abstract: The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.
    Type: Application
    Filed: March 27, 2013
    Publication date: March 12, 2015
    Applicant: FIDIA FARMACEUTICI S.p.A.
    Inventors: Anna Maria Zanellato, Vincenza Corsa, Giancarlo Carpanese, Monica Campisi
  • PROCESS FOR THE PRODUCTION OF HYALURONIC ACID IN ESCHERICHIA COLI OR BACILLUS MEGATERIUM
    Publication number: 20140099673
    Abstract: The present invention relates to a method of producing hyaluronic acid (HA) in Escherichia coli and Bacillus megaterium through episomal plasmid vectors wherein the gene is under the control of strong promoter T7, preferably under the control of strong promoter T7 of bacteriophage T7, and a system for the selection of stable bacterial strains producing high levels of hyaluronic acid.
    Type: Application
    Filed: September 9, 2011
    Publication date: April 10, 2014
    Applicant: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza Corsa, Alessandro Negro, Sonia Bisicchia
  • PROCESS FOR THE PRODUCTION OF HYALURONIC ACID IN ESCHERICHIA COLI OR BACILLUS SUBTILIS
    Publication number: 20130189740
    Abstract: The present invention relates to a method for the production of hyaluronic acid (HA) in Bacillus subtilis and Escherichia coli through plasmid vectors wherein the gene is under the control of strong promoter Pgrac, and a system for the selection of stable bacterial strains for the production of high levels of hyaluronic acid.
    Type: Application
    Filed: September 9, 2011
    Publication date: July 25, 2013
    Applicant: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza Corsa, Alessandro Negro, Susanna Vaccaro, Luciano Messina